cas 132800-13-6|| where to buy 1-cyclobutylpiperazine

Produktname:1-cyclobutylpiperazine

IUPAC Name:1-cyclobutylpiperazine

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM169812-250mg	in stock	Ǡǲ
CM169812-1g	in stock	ſſȱ
CM169812-5g	in stock	ƼǠƼ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 132800-13-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:132800-13-6; Molekulare Formel:C8H16N2; Schmelzpunkt:-; SMILES-Code:N1(C2CCC2)CCNCC1; Dichte:

: Katalognummer:CM169812; Molekulargewicht:140.23; Siedepunkt:290.8°C at 760 mmHg; Mdl-Nr.:MFCD06254806; Lagerung:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.